earnings
confidence medium
sentiment negative
materiality 0.75
ICU Medical Q2 revenue up 8.6% to $596.5M but GAAP net loss widens to $21.4M; adjusted EPS down to $1.56
ICU MEDICAL INC/DE
2024-Q2 EPS reported
-$2.51
revenue$1,163,110,000
- Revenue $596.5M up 8.6% YoY from $549.3M; GAAP gross margin 35% unchanged.
- GAAP net loss $(21.4)M ($0.88 loss per diluted share) vs $(9.9)M loss ($0.41) in Q2 2023.
- Adjusted diluted EPS $1.56 vs $1.88 YoY; adjusted EBITDA $91.3M down from $98.1M.
- Fiscal 2024 guidance updated; details not included in this excerpt.